Pharmafile Logo
Pharmafocus logo
Advanced Search

depression

Showing 15 posts of 52 posts found.

mental-health-2019924_640

Five crucial facts about mental health

April 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …

Feature
cognition_kit

Takeda collaborates to launch wearable-tech depression study

February 23, 2017
Medical Communications, Research and Development Takeda, depression, mental health, wearable tech

Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …

News
pillsphotos1

Research suggests that anti-inflammatory drugs may offer alternative to anti-depressants

October 18, 2016
Manufacturing and Production University of Cambridge, anti-cytokine, anti-inflammatory, depression

Researchers at the University of Cambridge analysed data from 20 clinical trials involving anti-cytokine drugs, which are commonly used to …

News
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016
Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …

News
Rexulti (brexpiprazole)

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015
Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …

News
Campbell image

Changing our minds about depression

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind

Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …

Feature
Kofi Annan speaks at the 'global crisis of depression' summit hosted in Lo

Mental and physical health should be treated equally

November 26, 2014
Medical Communications, Research and Development, Sales and Marketing Campbell, Lundbeck, depression, kofi annan, wiinberg

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

News

FDA accepts new schizophrenia drug filing

September 24, 2014
Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia

The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …

News

Google’s Calico takes first steps into research

September 12, 2014
Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease

Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …

News
App image

Lilly app targets depression

June 10, 2014
Medical Communications, Sales and Marketing Android, depression, iphone, lilly, talking progress

Eli Lilly has launched a free mobile app for Android and iPhone handsets which aims to support patients who suffer …

News

No closer to Alzheimer’s cure despite rise in research

October 21, 2013
Research and Development, Sales and Marketing Alzheimer's, depression, markram

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …

News

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013
Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

News
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012
Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …

News

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …

News

Kantar Health Launches Global Health and Wellness Quarterly Update

July 12, 2011
Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity

The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …

News
Press release

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023